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Abstract
Fractures are the feared consequences of osteoporosis and fractures of
the proximal femur (FPF) are those that involve the highest morbidity
and mortality. Thus far, evaluation of bone mineral density (BMD) is
the best way to determine the risk of fracture. Genetic inheritance, in
turn, is one of the major determinants of BMD. A correlation between
different genotypes of the vitamin D receptor (VDR) and BMD has
been recently reported. On this basis, we decided to determine the
importance of the determination of VDR genotype in the presence of
an osteoporotic FPF in a Brazilian population. We studied three
groups: group I consisted of 73 elderly subjects older than 65 years
(78.5 ± 7.2 years) hospitalized for nonpathological FPF; group II
consisted of 50 individuals older than 65 years (72.9 ± 5.2 years)
without FPF and group III consisted of 98 young normal Brazilian
individuals aged 32.6 ± 6.6 years (mean ± SD). Analysis of VDR gene
polymorphism by restriction fragment length polymorphism (RFLP)
was performed by PCR amplification followed by BsmI digestion of
DNA isolated from peripheral leukocytes. The genotype distribution
in group I was 20.5% BB, 42.5% Bb and 37% bb and did not differ
significantly from the values obtained for group II (16% BB, 36% Bb
and 48% bb) or for group III (10.2% BB, 47.6% Bb and 41.8% bb). No
differences in genotype distribution were observed between sexes or
between the young and elderly groups. We conclude that determina-
tion of VDR polymorphism is of no practical use for the prediction of
FPF. Other nongenetic factors probably start to affect bone mass, the
risk to fall and consequently the occurrence of osteoporotic fractures
with advancing age.
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Introduction
About 25% of American menopausal
women are expected to suffer a bone frac-
ture due to osteoporosis (1). Fractures of
the proximal femur (FPF) are associated
with a larger number of deaths, with dis-
ability and greater medical costs than all
other osteoporotic fractures taken together
(2,3) and therefore represent a consider-
able socioeconomic problem. The risk for
osteoporotic fractures is inversely corre-
lated with the amount of bone mass in an
individual and genetic inheritance is con-
sidered to be a major determinant respon-
sible for 60 to 80% of bone mass (4). The
search for a genetic marker for osteoporo-
sis interests many researchers worldwide
in view of the socioeconomic impact of
this disease. Morrison et al. (5) suggested
that the alleles of the vitamin D receptor
(VDR) may be of high predictive value in
the quantification of bone mass in an indi-
vidual. Although later studies conducted
on different racial groups in different coun-
tries have produced conflicting results (6-
8), we observed the same correlation as
that reported by Morrison et al. in a popu-
lation of 126 premenopausal Brazilian
women from the city of São Paulo (9). We
reported that a group of women with a BB
genotype had, on average, a lower bone
mineral density (BMD) than women with
the bb genotype and this difference was
more significant in a region of the neck of
the femur.
Few studies, however, are available
about the determination of VDR polymor-
phism in the presence of osteoporotic frac-
tures and all of them concern vertebral
fractures. No study has correlated VDR
polymorphism with osteoporotic FPF.
Thus, the objective of the present study
was to determine the practical usefulness
of the determination of VDR genotype for
the prediction of FPF risk in a Brazilian
population.
Patients and Methods
Three groups were evaluated in the
present study. Group I consisted of 73
patients aged 65 years or older consecu-
tively admitted to the Orthopedics De-
partment of two teaching hospitals in the
city of São Paulo for FPF. Patients whose
fracture was due to the presence of local
neoplasia or bone metastases were ex-
cluded from the study. The patients re-
ported their history of disease and of use
of medications and the data were con-
firmed in the medical records during hos-
pitalization. The associated diseases of
the patients studied were: diabetes melli-
tus (DM) in 17 (23.2%), systemic arterial
hypertension (SAH) in 27 (37%), heart
disease in 9 (12.3%), senile dementia in 6
(8.2%), osteoarthrosis in 5 (6.8%), and
treated primary hypothyroidism in 1
(1.4%). Only 8% of these patients were
aware of the fact that they had osteoporo-
sis and were taking calcium, vitamin D
and/or calcitonin. Eleven patients (15%)
took thiazides, 9 (12.3%) took oral hy-
poglycemic agents, 13 (17.8%) took anti-
hypertensive agents, and 3 (4.1%) took
anxiolytic and/or psychotropic agents.
Group II consisted of 50 individuals
without current or previous FPF of a simi-
lar age range (≥ 65 years) consecutively
seen at the Geriatrics Outpatient Clinic of
one of the teaching hospitals. Patients
known to have neoplasias were excluded
from this group of aged subjects without
FPF. In this group, 7 patients (14%) had
DM, 27 (54%) had SAH, 2 (4%) had heart
disease, 5 (10%) had dyslipidemias, 3 (6%)
had chronic bronchitis, 3 (6%) had
osteoarthrosis, and 1 (2%) had treated pri-
mary hypothyroidism. Among the medi-
cations taken by these individuals were
thiazides (9 individuals, 18%), oral hy-
poglycemic drugs (4 individuals, 8%), an-
tihypertensive drugs (14 individuals, 28%),
and anxiolytics (1 individual, 2%).
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Finally, group III consisted of 98 young
healthy volunteers ranging in age from 18 to
45 years, all of them employees of the Fed-
eral University of São Paulo.
Because of the many races and rich mis-
cegenation occurring in Brazil, we divided
the individuals into white, black, crossbred
(white with black and/or Indian) and orien-
tal.
All individuals in groups I and II were
submitted to a questionnaire that evaluated
racial characteristics and daily ingestion of
dairy calcium. Ingestion of dairy calcium
has been characterized as the number of
glasses of milk drunk in a day as well as the
ingestion of milk by-products (yoghurt,
cheese, clabber). According to these data,
the patients were classified into three groups:
1) those ingesting less than 500 mg calcium/
day; 2) those ingesting 500 to 1000 mg/day,
and 3) those ingesting more than 1000 mg/
day. The questionnaires were filled out by
the same interviewer.
The protocol was approved by the Medi-
cal Ethics Committee of the Federal Univer-
sity of São Paulo, and all subjects gave in-
formed consent to participate in the study.
A blood sample was collected from each
subject for extraction of genomic DNA. All
laboratory tests were carried out in the Endo-
crinology Laboratory of the Federal Univer-
sity of São Paulo.
Restriction fragment length polymor-
phism method (RFLP): genomic DNA was
extracted from peripheral blood leucocytes
using a commercial kit (Puregene, Gentra
Systems, Inc., Minneapolis, MN). The de-
sired fragments of the receptor gene were
amplified by the polymerase chain reaction
(PCR) using the same primers as described
by Morrison et al. (10). The PCR product
was submitted to digestion with the BsmI
restriction enzyme for 3 h and the fragments
were separated by agarose gel electrophore-
sis and photographed. The genotype denoted
BB does not have the restriction site recog-
nized by the enzyme, and therefore presents
a band of 800 bp. The bb genotype appears
as two bands of 650 and 150 bp, and the Bb
heterozygote is recognized by presenting 3
bands of 800, 650 and 150 bp.
Statistical analysis
The data are reported as means ± SD and
medians. Statistical analysis for comparison
of two groups of data was performed by the
nonparametric Mann-Whitney test since most
of the data did not present normal distribu-
tion. The variation in the distribution of the
three VDR genotypes (BB, Bb and bb) in the
groups studied was compared by the chi-
square test. The level of significance was set
at P≤0.05. The crude odds ratio and the ratio
adjusted for sex, age and race were obtained
by 95% point and confidence intervals using
unconditional logistic regression. Dairy cal-
cium ingestion data were compared by the
chi-square test.
Results
Of the 73 patients in group I, 56 (76.7%)
were women and 17 (23.3%) were men, with
a female/male ratio of 3.3/1. Age ranged
from 65 to 94 years, with a mean ± SD of
78.52 ± 7.2 years and a median of 78 years.
There was a geometric increase in fractures
with age range, with 42.4% of them occur-
ring in patients 80 years or older. When the
patients were divided into subgroups ac-
cording to different age levels within sex, the
largest number of cases of FPF in men was
found to occur from the age of 75 years,
when the number of FPF doubled (58.7%),
while in women the frequency almost
doubled later, starting at the age of 80 years
(48.2%) (Figure 1). With respect to racial
distribution, there was a lower predominance
of fractures among blacks and a higher pre-
dominance among orientals than in the group
II. The racial composition of the group was
56 whites (76.7%), 12 crossbreds (16.4%), 4
orientals (5.3%) and only one black (1.4%).
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confidence interval of 0.6 to 4.62, a nonsig-
nificant value (P>0.32). The presence in the
model of sex, race and age did not affect this
result. Using the odds ratio to compare the
frequency of BB in group I with the fre-
quency in groups II and III (patients without
FPF), we did not find a statistically signifi-
cant difference (odds ratio = 2.0; confidence
interval = 0.88 to 4.55; P = 0.1), even when
considering variables such as sex, race and
age.
The frequency of BB was higher in the
elderly groups (18.6% for groups I and II as
a whole) compared to group III (10.2%), but
the difference was not statistically signifi-
cant (P = 0.17). Using the odds ratio to
compare the frequency of BB in the elderly
groups (group I and group II) with the young
group (group III), we did not find significant
differences (odds ratio = 1.85; confidence
interval = 0.79 to 4.32; P = 0.16).
The distribution of genotypes among the
various racial groups is presented in Table 1.
There was a predominance of allele b in the
oriental group, in which the homozygous B
genotype was absent. Curiously, there was
an increased proportion of the bb genotype
among blacks (58.8%) compared to whites
and crossbreds as a whole (38.9%), but the
difference was not statistically significant (P
= 0.071).
Genotype distribution was similar for the
two sexes: men presented 40.3% bb, 43.4%
Bb and 11.3% BB and women presented
42.1% bb, 41.5% Bb and 16.3% BB (P =
0.52). The analysis of the distribution of
VDR genotype only in group I and II women
did not show a significant difference (P =
0.39), even when considering only white
women (P = 0.62) (Table 2).
Dairy calcium ingestion was similar for
groups I and II, in which 34.5% of patients
with fractures and 40% of subjects with no
fractures ingested <500 mg calcium/day (P =
0.36). Also, there was no significant differ-
ence in calcium ingestion between the vari-
ous genotypes (P = 0.2).
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Figure 1 - Age and sex distribu-
tion of the patients with fracture
of the proximal femur.
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Figure 2 - Distribution of vitamin
D receptor gene polymorphism
among the three groups studied
(group I = elderly subjects with
FPF, group II = elderly subjects
without FPF and group III =
young healthy subjects).
Of the 50 individuals in group II, 36
(72%) were women and 14 (28%) were men.
Mean ± SD age was 72.9 ± 5.2 years and the
median was 72 years (range: 64-85 years).
The racial composition of the group was 38
whites (76%), 5 blacks (10%), 7 crossbreds
(14%), and no orientals.
Of the 98 individuals in group III, 67
(68.4%) were women and 31 (31.6%) were
men. Mean ± SD age was 32.6 ± 6.6 years
and the median was 33 years (range: 18-45
years). The racial composition of the group
was 64 whites (65.3%), 11 blacks (11.2%),
21 crossbreds (21.4%), and 2 orientals (2.0%).
The distribution of the various VDR geno-
types (BB, Bb and bb) was similar for the
three groups (Figure 2). A slight predomi-
nance of genotype BB (20.5%) was observed
in group I compared to group II (16%) and
group III (10.2%), but the difference was not
statistically significant (P = 0.23). Allele B
was detected in 41.7% of the individuals in
group I and in 34% of the individuals in
group II, the difference again being nonsig-
nificant (P = 0.3). To better compare the
frequency of BB and bb in group I and group
II, we obtained the odds ratio of 1.67 with a
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Discussion
The present study was the first in which
the correlation between VDR polymorphism
and the occurrence of FPF was evaluated. It
was centered on the role of the VDR geno-
types described by Morrison et al. (5) in the
occurrence of osteoporotic FPF. Although
our data showed a larger number of BB
genotypes in the group of patients with frac-
tures, the chi-square test showed that this
difference was not sufficient to rule out ran-
dom sampling variability. The other two
genotypes were also equally frequent in the
group of patients with fractures compared to
the other groups. Since most studies in the
literature refer to VDR genotype in women,
we analyzed our data only in women and we
did not find any predominant VDR genotype
in women with FPF compared to women
without FPF. Thus, the determination of VDR
genotype would be of no predictive value for
the risk of fracture of the proximal femur of
an individual. However, it is important to
consider that there was a higher frequency of
BB in group I that we believe would lead to
statistical significance if the number of pa-
tients were higher. We excluded the influ-
ence of variables such as sex, age and race
from the model, and these variables did not
influence the results.
In agreement with our results, other au-
thors did not find a correlation between VDR
genotypes and fractures. However, all the
previous studies concern only vertebral frac-
tures. Hayes et al. (11) evaluated the correla-
tion between the genotypes determined with
another restriction enzyme, TaqI, and the
length of the femoral head, a characteristic
linked to the risk of local fracture, but did not
demonstrate the importance of genotype
among individuals who had already suffered
a fracture. Houston et al. (12), in the UK,
evaluated the correlation of VDR polymor-
phism with the occurrence of vertebral frac-
tures and did not identify any predominant
genotype in this type of fracture. In another
study, Francis et al. (13) did not identify any
predominant genotype in a group of men
with vertebral crush fractures. In contrast,
Yanagi et al. (14), in a study on Japanese
women, demonstrated that the frequency of
BB genotypes increases considerably from
3% in the control group to 24% in a group of
women with osteoporosis with vertebral frac-
tures.
Although we did not measure BMD, we
believe that a low BMD is of little signifi-
cance if it does not imply a larger number of
fractures. Most of the studies on VDR
polymorphisms are based on the correlation
between BMD and the genotypes defined. In
the present study, our concern was to objec-
tively analyze the significance of genotype
in terms of the prediction of the risk of
fracture in an individual, and our results
showed that this factor cannot be used to
define a higher risk of FPF.
Although BMD is known to play an im-
Table 1 - VDR genotype distribution among different races in the groups of young
individuals, elderly subjects without fractures and elderly subjects with fractures.
White ¬ Black ¬ Crossbred ¬ Oriental. χ2 = 8.52. P = 0.2027.
Genotype
BB Bb bb Total
White 25 (15.8%) 71 (44.9%) 62 (39.2%) 158 (100%)
Black 4 (23.5%) 3 (17.6%) 10 (58.8%) 17 (100%)
Crossbred 4 (10%) 21 (52.2%) 15 (37.5%) 40 (100%)
Oriental 0 (0%) 2 (33.3%) 4 (66.6%) 6 (100%)
Total 33 (14.9%) 97 (43.9%) 91 (41.2%) 221 (100%)
Table 2 - VDR genotype distribution in women with and without fractures of the
proximal femur (FPF).
With FPF ¬ without FPF. χ2 = 1.8. P = 0.39.
Genotype
BB Bb bb Total
Women with FPF 13 (23.2%) 23 (41.1%) 20 (35.7%) 56 (100%)
Women without FPF 7 (19.4%) 11 (30.5%) 18 (50%) 36 (100%)
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portant role in the risk of fracture, the occur-
rence of FPF is not justified simply by a
reduction in BMD. Other factors that do not
depend on BMD are also involved, such as
those that increase the risk of falls for an
elderly individual (15).
There is a variation in the distribution of
VDR alleles among different racial groups.
In oriental countries such as Japan the fre-
quency of BB is low in the general popula-
tion (16). In agreement with this fact, we did
not detect any BB genotype in the 6 indi-
viduals of oriental extraction who partici-
pated in the present study. Although the
number of subjects involved is small, these
data agree with those observed in another
study conducted on a population of pre-
menopausal women in the city of São Paulo
(9), where the B allele was found only in
16.6% of orientals, in contrast to 60.8% of
whites and 74.9% of blacks and crossbreds.
Although there are clear population dif-
ferences in the distribution of VDR geno-
types, the environmental or life style factors
that might explain them are unknown. Cal-
cium ingestion and assimilation may be one
of these factors, as previously demonstrated
(17,18). In the present study there was no
difference in the ingestion of dairy calcium
between groups I and II. Also, there was no
significant difference in calcium ingestion
between the various genotypes.
The study also permitted us to determine
some of the epidemiologic characteristics of
FPF in the city of São Paulo, Brazil, which
had not been studied previously. The hospi-
tals where the patients were studied are large
public teaching hospitals which are repre-
sentative of the entire population.
The female/male ratio of osteoporotic
FPF was 3.3/1, a value similar to the 3.8/1
ratio reported for the La Plata region of
Argentina (19). It should be pointed out that
in Brazil, a country of continental dimen-
sions and with a wide variety of ethnic groups,
costumes and dietary habits, if the popula-
tions of the North or Center of the country
were studied, the data obtained may differ
from those reported here. Almost half the
FPF of our patients occurred after 80 years of
age and the exponential increase in FPF with
age observed in our group has been previ-
ously reported by several investigators
(2,19,20). Only one black patient was ob-
served in the group of subjects with FPF
(1.4%), whereas groups II and III included
approximately 10% black subjects. This is in
agreement with the literature, which empha-
sizes the greater protection against osteoporo-
sis and fractures among blacks (21,22).
The discovery of VDR polymorphism as
a factor associated with reduced BMD in
many of the populations studied has led to an
advance in the study of osteoporosis by fi-
nally providing a genetic marker, even though
a weak one, although its physiopathological
significance has not been determined. How-
ever, the use of genotype determination as a
predictive factor for the risk of proximal
femur fracture did not prove to be valid in
the present study.
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